Literature DB >> 22649090

SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment.

Dennis J Hartigan-O'Connor1, Kristina Abel, Koen K A Van Rompay, Bittoo Kanwar, Joseph M McCune.   

Abstract

The mechanisms by which some HIV-infected subjects resist disease progression, whereas others progress rapidly, are incompletely understood. Viral and host genetic factors, such as nef deletions and major histocompatibility complex alleles, explain a portion of the observed variability. However, it has been difficult to identify host immune functions that may be present before infection and that allow resistance to lentiviral disease progression. Here, we show that simian immunodeficiency virus replication in the infected rhesus macaque is limited by the size of the preexisting T helper 17 (T(H)17) cell compartment: Animals with a high representation of such cells in blood and intestinal tissue before infection experienced peak and set-point viral loads about one log unit lower than those with a lower representation of T(H)17 cells. Reciprocally, treatment of macaques with interleukin-2 and granulocyte colony-stimulating factor before infection led to depletion of T(H)17 cells, reduction of the ratio between T(H)17 cells and CD3(+)CD4(+)CD25(+)CD127(low) regulatory T cells, and higher viral loads for 6 months after infection. These results demonstrate that the composition of the host immune system before infection has an influence on the course of disease after infection. Furthermore, to the extent that this influence shapes and interacts with T cell-mediated responses to virus, our findings provide a new framework for understanding interindividual variation in responses to therapies and vaccines against HIV.

Entities:  

Mesh:

Year:  2012        PMID: 22649090      PMCID: PMC3520607          DOI: 10.1126/scitranslmed.3003941

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  44 in total

1.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

Authors:  Wei Jiang; Michael M Lederman; Peter Hunt; Scott F Sieg; Kathryn Haley; Benigno Rodriguez; Alan Landay; Jeffrey Martin; Elizabeth Sinclair; Ava I Asher; Steven G Deeks; Daniel C Douek; Jason M Brenchley
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

2.  Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.

Authors:  Nicholas J Maness; Levi J Yant; Chungwon Chung; John T Loffredo; Thomas C Friedrich; Shari M Piaskowski; Jessica Furlott; Gemma E May; Taeko Soma; Enrique J León; Nancy A Wilson; Helen Piontkivska; Austin L Hughes; John Sidney; Alessandro Sette; David I Watkins
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

Authors:  Jason M Brenchley; Mirko Paiardini; Kenneth S Knox; Ava I Asher; Barbara Cervasi; Tedi E Asher; Phillip Scheinberg; David A Price; Chadi A Hage; Lisa M Kholi; Alexander Khoruts; Ian Frank; James Else; Timothy Schacker; Guido Silvestri; Daniel C Douek
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

Review 4.  Th17 cytokines and the gut mucosal barrier.

Authors:  Christoph Blaschitz; Manuela Raffatellu
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

Review 5.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

6.  A microbial symbiosis factor prevents intestinal inflammatory disease.

Authors:  Sarkis K Mazmanian; June L Round; Dennis L Kasper
Journal:  Nature       Date:  2008-05-29       Impact factor: 49.962

7.  Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.

Authors:  Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

Review 8.  The roles of IL-17A in inflammatory immune responses and host defense against pathogens.

Authors:  Yoichiro Iwakura; Susumu Nakae; Shinobu Saijo; Harumichi Ishigame
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

9.  Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection.

Authors:  David Favre; Sharon Lederer; Bittoo Kanwar; Zhong-Min Ma; Sean Proll; Zeljka Kasakow; Jeff Mold; Louise Swainson; Jason D Barbour; Carole R Baskin; Robert Palermo; Ivona Pandrea; Christopher J Miller; Michael G Katze; Joseph M McCune
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

10.  TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys.

Authors:  So-Yon Lim; Thomas Rogers; Tiffany Chan; James B Whitney; Jonghwa Kim; Joseph Sodroski; Norman L Letvin
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more
  24 in total

1.  IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8+ T Cell Responses in Acute Simian Immunodeficiency Virus Infection.

Authors:  Gema Méndez-Lagares; Ding Lu; David Merriam; Christopher A Baker; François Villinger; Koen K A Van Rompay; Joseph M McCune; Dennis J Hartigan-O'Connor
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

2.  Breast-fed and bottle-fed infant rhesus macaques develop distinct gut microbiotas and immune systems.

Authors:  Amir Ardeshir; Nicole R Narayan; Gema Méndez-Lagares; Ding Lu; Marcus Rauch; Yong Huang; Koen K A Van Rompay; Susan V Lynch; Dennis J Hartigan-O'Connor
Journal:  Sci Transl Med       Date:  2014-09-03       Impact factor: 17.956

3.  Plasma n-6 Fatty Acid Levels Are Associated With CD4 Cell Counts, Hospitalization, and Mortality in HIV-Infected Patients.

Authors:  Edmond K Kabagambe; Amara E Ezeamama; David Guwatudde; Hannia Campos; Wafaie Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

4.  HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes.

Authors:  Haitao Guo; Jianmei Gao; Debra J Taxman; Jenny P Y Ting; Lishan Su
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

Review 5.  Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.

Authors:  Joern E Schmitz; Birgit Korioth-Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

Review 6.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 7.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

8.  Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.

Authors:  Aaron Christensen-Quick; Mark Lafferty; Lingling Sun; Luigi Marchionni; Anthony DeVico; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

9.  Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge.

Authors:  Chris A R Baker; Louise Swainson; Din L Lin; Samson Wong; Dennis J Hartigan-O'Connor; Jeffrey D Lifson; Alice F Tarantal; Joseph M McCune
Journal:  Sci Transl Med       Date:  2015-08-12       Impact factor: 17.956

10.  Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes.

Authors:  Koen K A Van Rompay; Said Hassounah; Brandon F Keele; Jeffrey D Lifson; Amir Ardeshir; Jennifer Watanabe; Hanh Thi Pham; Elena Chertova; Raymond Sowder; Jan Balzarini; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.